Receptor changes in cerebral arteries after subarachnoid haemorrhage

Acta Neurologica Scandinavica

Volumn 109, Issue 1, 2004, Pages 33-44

  Hansen Schwartz, Jacob ^a,b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Mental Health Services CPH   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

5 hydroxytryptamine receptors; Endothelin receptors; in vitro pharmacology; Organ culture; Reverse transcriptase polymerase chain reaction; Subarachnoid haemorrhage

Indexed keywords

3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; AMIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOHEXAMIDE; DACTINOMYCIN; ENDOTHELIN 1; ENDOTHELIN 1 [11-21]; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR AGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; SARAFOTOXIN S6C; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; BRAIN VASOSPASM; CEREBROVASCULAR DISEASE; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SUBARACHNOID HEMORRHAGE;

ANIMALS; ENDOTHELIN-1; PHENOTYPE; RATS; RECEPTORS, ENDOTHELIN; RECEPTORS, SEROTONIN; SUBARACHNOID HEMORRHAGE; UP-REGULATION; VASOSPASM, INTRACRANIAL;

EID: 0742286860     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00170.x     Document Type: Article

References (94)

1. SÄVELAND H, HILLMAN J, BRANDT L, JAKOBSSON GE, EDNER G, ALGERS G. Symptomatic vasospasm after aneurysmal SAH. In: FINDLAY JM, ed. Cerebral vasospasm. Amsterdam: Elsevier, 1993;7-10.
2. WILKINS RH. Attempted prevention or treatment of intracranial arterial spasm: a survey. Neurosurgery 1980;6:198-210.
3. WILKINS RH. Attempts at prevention or treatment of intracranial arterial spasm: an update. Neurosurgery 1986;18:808-25.
4. ECKER A, RIEMENSCHNEIDER PA. Arteriographic demonstration of spasm of the intracranial arteries. J Neurosurg 1951;8:660-7.
5. KÅGSTRÖM E, GREITZ T, HANSON J, GALERA R. Changes in cerebral blood flow after subarachnoid haemorrhage. Excerpta Medica Int Cong Series 1966;110:629-33.
6. BERGVALL U, STEINER L, FORSTER DM. Early pattern of cerebral circulatory disturbances following subarachnoid haemorrhage. Neuroradiology 1973:5:24-32.
7. HEILBRUN MP, OLESEN J, LASSEN NA. Regional cerebral blood flow studies in subarachnoid hemorrhage. J Neurosurg 1972;37:36-44.
8. HUGHES JT, SCHIANCHI PM. Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage. J Neurosurg 1978;48:515-25.
9. WELLUM GR, IRVINE TW, ZERVAS NT. Dose responses of cerebral arteries of the dog, rabbit, and man to human hemoglobin in vitro. J Neurosurg 1980;53:486-90.
10. TANISHIMA T. Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg 1980;53:787-93.
11. TSUJI T, WEIR BK, COOK DA. Time-dependent effects of extraluminally- applied oxyhemoglobin and endothelial removal on vasodilator responses in isolated, perfused canine basilar arteries. Pharmacology 1989;38:101-12.
12. NISHIZAWA S, NEZU N, UEMURA K. Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;76: 635-9.
13. YOKOTA M, PETERSON JW, KAOUTZANIS MC, YAMAKAWA K, SIBILIA R, ZERVAS NT. Protein kinase C and diacylglycerol content in basilar arteries during experimental cerebral vasospasm in the dog. J Neurosurg 1995;82:834-40.
14. MINAMI N, TANI E, YOKOTA M, MAEDA Y, YAMAURA I. Immunohistochemistry of leukotriene C4 in experimental cerebral vasospasm. Acta Neuropathol (Berl) 1991;81:401-7.
15. ROSENBLUM WI. Endothelial dependent relaxation demonstrated in vivo in cerebral arterioles. Stroke 1986;17: 494-7.
16. TSUJI T, COOK DA. Alterations of canine cerebrovascular responses to vasopressin after endothelial removal. Pharmacology (Life Sci Adv) 1992;11:11-6.
17. TSUJI T, COOK DA. Biphasic response to substance P in canine basilar arteries. J Cardiovasc Pharmacol 1992; 20(Suppl. 12):S109-13.
18. ZIMMERMANN M, SEIFERT V. Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 1998;43:863-75.
19. SVENDGAARD NA, DELGADO-ZYGMUNT TJ, ARBAB MA. Anatomical and pathophysiological studies supporting the involvement of a reflex mechanism in cerebral vasospasm in the squirrel monkey. In: SANO K et al. eds. Cerebral vasospasm. Tokyo: University of Tokyo Press, 1990; 145-50.
20. SVENDGAARD NA, EDVINSSON L, OWMAN C, SAHLIN C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg Neurol 1977;8:191-5.
21. JUUL R, HARA H, GISVOLD SE et al. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man. Acta Neurochir (Wien) 1995;132:32-41.
22. European CGRP in Subarachnoid Haemorrhage Study Group. Effect of calcitonin-gene-related peptide in patients with delayed postoperative cerebral ischaemia after aneurysmal subarachnoid haemorrhage. Lancet 1992;339:831-4.
23. JUUL R, AAKHUS S, BJORNSTAD K, GISVOLD SE, BRUBAKK AO, EDVINSSON L. Calcitonin gene-related peptide (human alpha-CGRP) counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett 1994;170:67-70.
24. EDVINSSON L, DELGADO-ZYGMUNT T, EKMAN R, JANSEN I, SVENDGAARD NA, UDDMAN R. Involvement of perivascular sensory fibers in the pathophysiology of cerebral vasospasm following subarachnoid hemorrhage. J Cereb Blood Flow Metab 1990;10:602-7.
25. EDVINSSON L, JUUL R, JANSEN I. Perivascular neuropeptides (NPY, VIP, CGRP and SP) in human brain vessels after subarachnoid haemorrhage. Acta Neurol Scand 1994;90:324-30.
26. CHEHRAZI BB, GIRI S, JOY RM. Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1989;20:217-24.
27. GILLESPIE MN, OWASOYO JO, MCMURTRY IF, O'BRIEN RF. Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture. J Pharmacol Exp Ther 1986;236:339-43.
28. O'BRIEN RF, ROBBINS RJ, MCMURTRY IF. Endothelial cells in culture produce a vasoconstrictor substance. J Cell Physiol 1987;132:263-70.
29. YANAGISAWA M, KURIHARA H, KIMURA S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
30. HANSEN-SCHWARTZ J, EDVINSSON L. Endothelin. In: EDVINSSON L et al. eds. Cerebral blood flow and metabolism. New York: Lippincott, Williams & Wilkins, 2002;339-53.
31. EHRENREICH H, LANGE M, NEAR KA et al. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 1992;192:257-68.
32. MACCUMBER MW, ROSS CA, SNYDER SH. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc Natl Acad Sci U S A 1990;87:2359-63.
33. MURRAY MA, FARACI FM, HEISTAD DD. Effect of protein kinase C inhibitors on endothelin-and vasopressin-induced constriction of the rat basilar artery. Am J Physiol 1992;263:H1643-9.
34. KESKIL IS, BAYKANER MK, SENCER H et al. Alteration by Iloprost of the vasospastic effects of endothelin-1 in rabbit cerebral vessels. Neuroreport 1994;5:1089-92.
35. FARACI FM. Effects of endothelin and vasopressin on cerebral blood vessels. Am J Physiol 1989;257:H799-803.
36. GROSS PM, WAINMAN DS, ESPINOSA FJ, NAG S, WEAVER DF. Cerebral hypermetabolism produced by intraventricular endothelin-1 in rats: inhibition by nimodipine. Neuropeptides 1992;21:211-23.
37. GROSS PM, ZOCHODNE DW, WAINMAN DS, HO LT, ESPINOSA FJ, WEAVER DF. Intraventricular endothelin-1 uncouples the blood flow: metabolism relationship in periventricular structures of the rat brain: involvement of L-type calcium channels. Neuropeptides 1992;22:155-65.
38. MASAKI T, VANE JR, VANHOUTTE PM. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 1994;46:137-42.
39. 1994 Receptor and Ion Channel Nomenclature. Trends Pharmacol Sci 1994;(Suppl.):1-51.
40. ARAI H, HORI S, ARAMORI I, OHKUBO H, NAKANISHI S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990;348:730-2.
41. WATSON S, GIRDLESTONE D. TiPS on nomenclature. Trends Pharmacol Sci 1995;16:15-6.
42. TAKENAKA K, KISHINO J, ARITA H et al. Biological activity of the endothelin family in cultured basilar arterial smooth muscle cells. Neurol Res 1993;15:29-32.
43. VIGNE P, MARSAULT R, BREITTMAYER JP, FRELIN C. Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells. Biochem J 1990; 266:415-20.
44. A receptors. Eur J Pharmacol 1993;245:229-32.
45. FRELIN C, LADOUX A, MARSAULT R, VIGNE P. Function of vasoactive factors in the cerebral microcirculation. J Cardiovasc Pharmacol 1992;20(Suppl. 12):S94-6.
46. SZOK D, HANSEN-SCHWARTZ J, EDVINSSON L. In depth pharmacological characterization of endothelin B receptors in the rat middle cerebral artery. Neurosci Lett 2001;314:69-72.
47. ERSPAMER V, ASERO B. Identification of enteramine, specific hormone of enterochromaffin cells, as 5-hydroxtryptamine. Nature 1952;169:800-1.
48. RAPPORT MM, GREEN AA, PAGE IH. Crystalline serotonin. Science 1948;108:329-30.
49. BLOOM FE, KUPFER DJ. Psychopharmacology: The fourth generation of progress. New York: Raven Press, 1995.
50. OLESEN J, TFELT-HANSEN P, WELCH KMA. The headaches. Philadelphia: Lippincott, Williams & Wilkins, 2000.
51. EDVINSSON L, HARDEBO JE, OWMAN C. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res 1978;42:143-51.
52. EDVINSSON L, BIRATH E, UDDMAN R et al. Indoleaminergic mechanisms in brain vessels; localization, concentration, uptake and in vitro responses of 5-hydroxytryptamine. Acta Physiol Scand 1984;121:291-9.
53. LAMAR JC, EDVINSSON L. 5-Hydroxytryptamine receptors. Contractile activity and mode of inhibition by methysergide in mammalian intracranial and extracranial vessels. Arch Int Pharmacodyn Ther 1980;243:245-54.
54. EDVINSSON L, MACKENZIE ET, MCCULLOCH J. Cerebral blood flow and metabolism. New York: Raven Press, 1993.
55. IB receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Br J Pharmacol 1999;128: 1133-40.
56. EDVINSSON L, HARDEBO JE, MACKENZIE ET, STEWART M. Dual action of serotonin on pial arterioles in situ and the effect of propranolol on the response. Blood Vessels 1977;14:366-71.
57. HARPER AM, MACKENZIE ET. Effects of 5-hydroxytryptamine on pial arteriolar calibre in anaesthetized cats. J Physiol 1977;271:735-46.
58. HARPER MA, MACKENZIE ET. Cerebral circulatory and metabolic effects of 5-hydroxytryptamine in anesthetized baboons. J Physiol 1977;271:721-33.
59. MENDELOW AD, EIDELMAN BH, MCCALDEN TA, ROSENDOR C. Cerebrovascular response to infused 5-hydroxytryptamine in the baboon. Part 2. 5-Hydroxytryptamine infusion in estrogen and progesterone treated animals. Stroke 1977; 8:326-8.
60. OLESEN J. Effect of serotonin on regional cerebral blood flow (rCBF) in man. Cephalalgia 1981;1:7-10.
61. DAHLGREN N, LINDVALL O, NOBIN A, STENEVI U. Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems. Brain Res 1981;230:221-33.
62. MARCO EJ, MORENO MJ, DE PABLO AL. Local treatments of dorsal raphe nucleus induce changes in serotonergic activity in rat major cerebral arteries. Stroke 1999;30:1695-701.
63. GLENNON RA, DUKAT M, WESTKAEMPER RB. Serotonin receptor subtypes and ligands. In: BLOOM FE et al. eds. Psychopharmacology: the fourth generation of progress. New-York: Raven Press, 2000 (web update available at http:// www.acnp.org/g4/4thgen.php).
64. HOYER D, CLARKE DE. FOZARD JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46: 157-203.
65. HOYER D, HANNON JP, MARTIN GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharma-col Biochem Behav 2002;71:533-54.
66. MARTIN GR, EGLEN RM, HAMBLIN MW, HOYER D, YOCCA F. The structure and signalling properties of 5-HT receptors: an endless diversity? Trends Pharmacol Sci 1998;19:2-4.
67. VERHEGGEN R, FREUDENTHALER S, MEYER-DULHEUER F, KAUMANN AJ. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Br J Pharmacol 1996; 117:283-9.
68. JANSEN I, OLESEN J, EDVINSSON L. 5-Hydroxytryptamine receptor characterization of human cerebral, middle meningeal and temporal arteries: regional differences. Acta Physiol Scand 1993;147:141-50.
69. 1B/1D receptors during organ culture of cerebral arteries. Neuroreport 2001;12:1605-8.
70. CENTURION D, SANCHEZ-LOPEZ A, ORTIZ MT, DE VRIES P, SAXENA PR, VILLALON CM. Mediation of 5-HT-induced internal carotid vasodilatation in GR127935-and ritanserin-pretreated dog with 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol 2000;362:169-76.
71. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br J Pharmacol 1999;127:609-16.
72. 2B receptors. Br J Pharmacol 2000;130:692-8.
73. 2C receptor activation. Eur J Pharmacol 2000;401:221-7.
74. A receptor in human arteries in vitro. J Cardiovasc Pharmacol 1995;26(Suppl. 3):S314-6.
75. ADNER M, CANTERA L, EHLERT F, NILSSON L, EDVINSSON L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br J Pharmacol 1996;119: 1159-66.
76. HANSEN-SCHWARTZ J, EDVINSSON L. Increased sensitivity to ET-1 in rat cerebral arteries following organ culture. Neuroreport 2000;11:649-52.
77. NILSSON T, GANTERA L, ADNER M, EDVINSSON L. Presence of contractile endothelin-A and dilatory endothelin-B receptors in human cerebral arteries. Neurosurgery 1997; 40:346-51.
78. HANSEN-SCHWARTZ J, NORDSTRÖM CH, EDVINSSON L. Human endothelin subtype A receptor enhancement during tissue culture via de novo transcription. Neurosurgery 2002; 50:127-33.
79. IB receptor in cerebral arteries in rats. J Neurosurg 2003;99:115-20.
80. HANSEN-SCHWARTZ J, HOEL NL, ZHOU M, XU CB, SVENDGAARD NA, EDVINSSON L. Subarachnoid haemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 2003;52:1188-94.
81. B receptors in rat isolated small mesenteric arteries. Br J Pharmacol 1997;120:1376-82.
82. B receptor upregulation in rat mesenteric arteries. Eur J Pharmacol 2002;454:209-15.
83. HANSEN-SCHWARTZ J, SVENSSON CL, XU CB, EDVINSSON L. Protein kinase mediated upregulation of endothelin A, endothelin B and 5-hydroxytryptamine 1B/1D receptors during organ culture in rat basilar artery. Br J Pharmacol 2002;137:118-26.
84. WAY KJ, CHOU E, KING GL. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci 2000;21:181-7.
85. HANSEN-SCHWARTZ J, EDVINSSON L. Subarachnoid hemorrhage - extravasation of blood in the subarachnoid space. In: EDVINSSON L et al. eds. Cerebral blood flow and metabolism. New York: Lippincott, Williams & Wilkins, 2002;466-79.
86. PRUNEUL G, MATHIESEN T, SVENDGAARD NA. A new experimental model in rats for study of the pathophysiology of SAH. Neuroreport 2002;13:2553-6.
87. PRUNELL G, MATHIESEN T, DIEMER NH, SVENDGAARD NA. Experimental SAH: subarachnoid blood volume, mortality, neuronal death, CBF and perfusion pressure in three different models in the rat. Neurosurgery 2003;52:165-75.
88. B receptor contractile activity in rat cerebral artery. Neuroreport 1999;10:2355-9.
89. HINO A, TOKUYAMA Y, KOBAYASHI M et al. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 1996;16:688-97.
90. TSUJI T, ABROL RP, COOK DA. Actions of bradykinin on canine basilar arteries. In: RUBANYI GM et al. eds. Endothelium-derived relaxing factors. Basel: S. Karger, 1990; 191-7.
91. KIM P, LORENZ RR, SUNDT TM, VANHOUTTE PM. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg 1989;70:108-14.
92. KIM P, SCHINI VB, SUNDT TM, VANHOUTTE PM. Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res 1992;70:248-56.
93. B receptor mRNA in human cerebral arteries. Br J Neurosurg 2002;16:149-53.
94. THORIN E, NGUYEN TD, BOUTHILLIER A. Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke 1998;29:175-80.